Company intelligence / Profile preview
Kwang Dong Pharmaceutical Co., Ltd.
Seoul, South Koreaeng.ekdp.com ↗
- Ownership
- Public · A009290
- Employees
- ~1042
- Development stage
- Other
01
Overview
The company has multiple commercial products and a pipeline of drugs in various stages of development, from preclinical to approved. They have recently expanded their portfolio through acquisitions and partnerships.
- Therapeutic areas
- Men's HealthOphthalmologyImmunologyWomen's HealthOncologyRare DiseasesNeurology
- Modalities
- Small molecule drugsSynthetic peptides
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
03
Partnerships
Zhaoke OphthalmologyChiesi FarmaceuticiPalatin TechnologiesGSK
04
Financials
- Market cap
- $229.5M
- Total revenue
- $1.2B
- Enterprise value
- $320.5M
Beyond the preview
Go deeper on Kwang Dong Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kwang Dong Pharmaceutical Co., Ltd..